425 related articles for article (PubMed ID: 20347025)
1. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
2. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
3. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.
Han SE; Kang H; Shim GY; Suh MS; Kim SJ; Kim JS; Oh YK
Int J Pharm; 2008 Apr; 353(1-2):260-9. PubMed ID: 18178348
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles.
Vandenbroucke RE; Lentacker I; Demeester J; De Smedt SC; Sanders NN
J Control Release; 2008 Mar; 126(3):265-73. PubMed ID: 18237813
[TBL] [Abstract][Full Text] [Related]
5. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide.
Lee SH; Kim SH; Park TG
Biochem Biophys Res Commun; 2007 Jun; 357(2):511-6. PubMed ID: 17434451
[TBL] [Abstract][Full Text] [Related]
6. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
Li W; Huang Z; MacKay JA; Grube S; Szoka FC
J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency.
Kim JK; Choi SH; Kim CO; Park JS; Ahn WS; Kim CK
J Pharm Pharmacol; 2003 Apr; 55(4):453-60. PubMed ID: 12803766
[TBL] [Abstract][Full Text] [Related]
8. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA.
Kim HR; Kim IK; Bae KH; Lee SH; Lee Y; Park TG
Mol Pharm; 2008; 5(4):622-31. PubMed ID: 18461969
[TBL] [Abstract][Full Text] [Related]
9. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
Khoury M; Louis-Plence P; Escriou V; Noel D; Largeau C; Cantos C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2006 Jun; 54(6):1867-77. PubMed ID: 16729293
[TBL] [Abstract][Full Text] [Related]
10. Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver.
Liu L; Zern MA; Lizarzaburu ME; Nantz MH; Wu J
Gene Ther; 2003 Jan; 10(2):180-7. PubMed ID: 12571647
[TBL] [Abstract][Full Text] [Related]
11. A hydroxyethylated cholesterol-based cationic lipid for DNA delivery: effect of conditioning.
Percot A; Briane D; Coudert R; Reynier P; Bouchemal N; Lièvre N; Hantz E; Salzmann JL; Cao A
Int J Pharm; 2004 Jun; 278(1):143-63. PubMed ID: 15158957
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Li SD; Huang L
Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
[TBL] [Abstract][Full Text] [Related]
13. Folate receptor targeted delivery of polyelectrolyte complex micelles prepared from ODN-PEG-folate conjugate and cationic lipids.
Kim SH; Jeong JH; Mok H; Lee SH; Kim SW; Park TG
Biotechnol Prog; 2007; 23(1):232-7. PubMed ID: 17269693
[TBL] [Abstract][Full Text] [Related]
14. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
Anwer K; Kao G; Proctor B; Rolland A; Sullivan S
J Drug Target; 2000; 8(2):125-35. PubMed ID: 10852344
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
Kim SH; Mok H; Jeong JH; Kim SW; Park TG
Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems.
Keller M; Harbottle RP; Perouzel E; Colin M; Shah I; Rahim A; Vaysse L; Bergau A; Moritz S; Brahimi-Horn C; Coutelle C; Miller AD
Chembiochem; 2003 Apr; 4(4):286-98. PubMed ID: 12672108
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery.
Heyes J; Hall K; Tailor V; Lenz R; MacLachlan I
J Control Release; 2006 May; 112(2):280-90. PubMed ID: 16603272
[TBL] [Abstract][Full Text] [Related]
18. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
[TBL] [Abstract][Full Text] [Related]
19. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations.
Ansell SM; Kojic LD; Hankins JS; Sekirov L; Boey A; Lee DK; Bennett AR; Klimuk SK; Harasym TO; Dos Santos N; Semple SC
Bioconjug Chem; 1999; 10(4):653-66. PubMed ID: 10411464
[TBL] [Abstract][Full Text] [Related]
20. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
